Locations:
Search IconSearch
September 14, 2015/Cancer

A New Minimally Invasive Option for Localized Prostate Cancer?

Robotic radical perineal prostatectomy has potential advantages

15-URL-082-Kaouk-Hero-Image-690x380pxl

By Jihad H. Kaouk, MD; Kenneth Angermeier, MD; and Oktay Akca, MD

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

At Cleveland Clinic’s Glickman Urological & Kidney Institute, we have explored the feasibility of robot-assisted radical perineal prostatectomy (RPP) with its inherent advantages of more direct access to the prostate and a small incision.

Since Young first described it in 1905, open RPP remained the most common surgical approach for the treatment of prostate cancer until the mid-1970s.

Urologists discontinued common performance of RPP due to concerns about the perineal anatomy; urologists are not generally familiar with the perineum since they routinely operate in the retropubic space and may be uncomfortable when operating close to the rectum. Additionally, the perineum is a deep and narrow space compared with the retropubic route.

Millin initially described the retropubic technique in 1945. Walsh et al. redefined the anatomical approach, applying the techniques of cavernous nerve sparing in the 1980s. For open surgery, the retropubic approach currently represents the preferred technique of most urologic surgeons based on habit rather than on evidence-based medicine.

Although the most widely used approach for open radical prostatectomy is the retropubic approach, there are no randomized studies demonstrating its superiority over the perineal approach in terms of cancer control and continence rates. Reported advantages of the perineal approach include shorter operative time and hospital stay, lower cost, and lower rates of postoperative urethral anastomosis stricture and inguinal hernia, owing to the lack of dissection and incision of the dorsal vascular complex, less blood loss and a lower rate of transfusion.

Advertisement

Rethinking RPP

Robot-assisted laparoscopic radical prostatectomy (RALP) was first described in the early 2000s and currently represents the most commonly performed surgical approach for the treatment of prostate cancer in the United States. The increase in RALP can be attributed to its short learning curve and the advantage of its articulating design over laparoscopy.

We wondered whether similar advantages could exist when using the robot specifically for RPP, with the hypothesis that robotic instruments could overcome tricky points of open RPP, such as working in a deep and narrow surgical area.

We initially developed a cadaver model to examine the applicability of the da Vinci robotic surgical system for RPP. We completed all steps of the nerve-sparing radical prostatectomy operation using five cadavers.

After obtaining Institutional Review Board approval for robotic RPP, we selected for the first procedures those patients diagnosed with localized prostate cancer and a risk for lymph node positivity of not more than 4 percent.

First Experience and Conclusions

The initial patient previously had undergone a total resection of his rectum to treat rectal cancer and had received pelvic radiotherapy. He was therefore living with an ileostomy. He also had mesh on the anterior abdominal wall owing to multiple hernia repairs.

Robotic RPP was completed successfully without complications, with an estimated blood loss of 50 cc. The patient was discharged on postoperative day one and was immediately continent when his urethral catheter was removed one week after surgery (Figures 1-4).

Advertisement

15-URL-082-Kaouk-Inset-Image-Figs-1-4-590pxl-width

Figure 1. Exaggerated lithotomy position. Figure 2. Robot docking, approaching from head and passing between legs. Figure 3. Incision closure. Figure 4. Robotic RPP specimen.

The potential technical advantages of robotic RPP over open RPP include the magnified view as well as the long, articulated robotic instruments, which may help minimize the difficulty of performing a procedure in such a narrow and deep surgical field.

In our initial patient, we were able to complete the procedure with an incision just large enough (4 cm) for specimen extraction. Minimizing the incision could also decrease postoperative pain and analgesia requirements.

In comparing robotic RPP with standard RALP, a perineal approach provides more direct access to the prostate than does the anterior abdominal wall, which allows for elimination of the first three steps commonly done in RALP (bladder mobilization, endopelvic fascia incision and dorsal vein complex dissection). Elimination of these steps could result in shorter operative time and less blood loss.

Robotic RPP eliminates risks of injury to abdominal organs and vessels, given its extraperitoneal nature. It might also be useful in those patients who have undergone a previous abdominal operation, similar to our initial patient and those who are severely obese.

In conclusion, the intersection of the da Vinci robotic surgical system and a natural anatomic approach to radical perineal prostatectomy might provide a new minimally invasive solution for patients diagnosed with localized prostate cancer.

Advertisement

Dr. Kaouk is Director of Cleveland Clinic Glickman Urological & Kidney Institute’s Center for Robotic and Laparoscopic Surgery and is the Urological & Kidney Institute’s Vice Chair for Surgical Innovations. He is Professor of Surgery at Cleveland Clinic Lerner College of Medicine.

Dr. Angermeier is a staff member of Cleveland Clinic Glickman Urological & Kidney Institute’s Department of Urology and Director of the Center for Genitourinary Reconstruction.

Dr. Akca is a research fellow in the Department of Urology.

Advertisement

Related Articles

Interactive culinary medicine class
November 11, 2024/Cancer/Innovations
Integrative Oncology Improves Outcomes and Quality of Life

Combining mind, body and lifestyle practices in alignment with conventional cancer treatment

Pregnant woman
November 6, 2024/Cancer/News & Insight
Large Retrospective Study Finds Pregnancy Safe Among Young BRCA Carriers

Pregnancy did not appear to increase the risk of recurrence in patients or complications in their children

Young patient with cancer
October 25, 2024/Cancer/News & Insight
Multidisciplinary Care Model Supports Young People with Cancer

Integrated program addresses growing need for comprehensive cancer care among adolescents, young adults and adults under 50 with early onset cancers

Hurthle cell carcinoma
October 24, 2024/Cancer/News & Insight
Researchers Uncover Clues to Treating Rare Thyroid Cancer

Studies find mTOR inhibitor may play key role in treating Hurthle cell carcinoma

DNA
October 10, 2024/Cancer/Research
Blocking YES1 Protein Resensitizes Triple-Negative Breast Cancer to Treatment

Obstructing key protein allows for increased treatment uptake for taxane chemotherapy

Plan of care meeting
October 4, 2024/Cancer/Radiation Oncology
Five Years of Parallel Prospective Plan of Care Reviews

Radiation oncology department finds weekly plan of care meetings have multiple benefits

Ad